Thomas T, Burguera B, Melton L J, Atkinson E J, O'Fallon W M, Riggs B L, Khosla S
Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN, USA.
Metabolism. 2000 Oct;49(10):1278-84. doi: 10.1053/meta.2000.9519.
Whether the higher serum leptin levels in women are due to gender differences in fat mass or to other factors such as sex steroids remains unclear. In addition to sex steroids, serum insulin levels also appear to be related to leptin levels, although whether this effect is independent of the effects of body composition is unclear. The purpose of this study was to identify the major determinants of circulating serum leptin levels. We studied a large, population-based cohort of 345 men (23 to 90 years), 137 premenopausal women (21 to 54 years), and 212 postmenopausal women (34 to 94 years), including 47 women on hormone replacement therapy (HRT). Serum leptin levels were related to body composition as assessed by dual-energy x-ray absorptiometry (DEXA) and to circulating sex steroid and insulin levels. Serum leptin levels remained significantly higher in women versus men even after adjustment for fat mass, and leptin levels were significantly correlated with fat mass independently of age. By univariate analyses, logarithmically transformed serum leptin levels correlated positively with bioavailable estrogen ([E] estradiol plus estrone) in postmenopausal women not on HRT, and negatively with total and bioavailable testosterone (T) levels in men. Serum insulin levels were directly related to leptin levels regardless of gender and age. By multivariate analyses, fat mass, lean mass, and insulin levels were the strongest predictors of leptin levels in all groups. In addition, bioavailable E entered the model in the postmenopausal women not on HRT. These studies indicate that the fat mass, lean mass, and insulin level are the major determinants of the serum leptin level in adults. Moreover, after adjusting for these variables, bioavailable E also explains a significant proportion of the variance in leptin levels among postmenopausal women not on HRT.
女性血清瘦素水平较高是由于脂肪量的性别差异,还是由于其他因素,如性类固醇,目前尚不清楚。除了性类固醇外,血清胰岛素水平似乎也与瘦素水平有关,尽管这种影响是否独立于身体成分的影响尚不清楚。本研究的目的是确定循环血清瘦素水平的主要决定因素。我们研究了一个基于人群的大型队列,其中包括345名男性(23至90岁)、137名绝经前女性(21至54岁)和212名绝经后女性(34至94岁),其中包括47名接受激素替代疗法(HRT)的女性。血清瘦素水平与通过双能X线吸收法(DEXA)评估的身体成分以及循环性类固醇和胰岛素水平有关。即使在调整脂肪量后,女性的血清瘦素水平仍显著高于男性,并且瘦素水平与脂肪量显著相关,与年龄无关。通过单变量分析,在未接受HRT的绝经后女性中,对数转换后的血清瘦素水平与生物可利用雌激素([E]雌二醇加雌酮)呈正相关,而在男性中与总睾酮和生物可利用睾酮(T)水平呈负相关。无论性别和年龄,血清胰岛素水平都与瘦素水平直接相关。通过多变量分析,脂肪量、瘦体重和胰岛素水平是所有组中瘦素水平的最强预测因素。此外,生物可利用E进入了未接受HRT的绝经后女性的模型。这些研究表明,脂肪量、瘦体重和胰岛素水平是成年人血清瘦素水平的主要决定因素。此外,在调整这些变量后,生物可利用E也解释了未接受HRT的绝经后女性瘦素水平差异的很大一部分。